Home
>
National Drug Code (NDC)
>
Hydrocodone Polistirex and Chlorpheniramine Polisitrex
Hydrocodone Polistirex and Chlorpheniramine Polisitrex - 49884-235-33 - (Hydrocodone Polistirex and Chlorpheniramine Polisitrex)
Drug Information of Hydrocodone Polistirex and Chlorpheniramine Polisitrex
| Product NDC: | 49884-235 |
| Proprietary Name: | Hydrocodone Polistirex and Chlorpheniramine Polisitrex |
| Non Proprietary Name: | Hydrocodone Polistirex and Chlorpheniramine Polisitrex |
| Active Ingredient(s): | 8; 10 mg/5mL; mg/5mL & nbsp; Hydrocodone Polistirex and Chlorpheniramine Polisitrex |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SUSPENSION, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Hydrocodone Polistirex and Chlorpheniramine Polisitrex
| Product NDC: | 49884-235 |
| Labeler Name: | Par Pharmaceutical Companies Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA091632 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120816 |
Package Information of Hydrocodone Polistirex and Chlorpheniramine Polisitrex
| Package NDC: | 49884-235-33 |
| Package Description: | 473 mL in 1 BOTTLE (49884-235-33) |
NDC Information of Hydrocodone Polistirex and Chlorpheniramine Polisitrex
| NDC Code | 49884-235-33 |
| Proprietary Name | Hydrocodone Polistirex and Chlorpheniramine Polisitrex |
| Package Description | 473 mL in 1 BOTTLE (49884-235-33) |
| Product NDC | 49884-235 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Hydrocodone Polistirex and Chlorpheniramine Polisitrex |
| Dosage Form Name | SUSPENSION, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20120816 |
| Marketing Category Name | ANDA |
| Labeler Name | Par Pharmaceutical Companies Inc |
| Substance Name | CHLORPHENIRAMINE MALEATE; HYDROCODONE BITARTRATE |
| Strength Number | 8; 10 |
| Strength Unit | mg/5mL; mg/5mL |
| Pharmaceutical Classes | Opioid Agonist [EPC],Opioid Agonists [MoA],Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] |
